Patient Education and Counseling
Volume 81, Issue 2 , Pages 245-250 , November 2010

Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

  • Robert A. Bell

      Affiliations

    • Department of Communication, University of California, Davis, CA, USA
    • Department of Public Health Sciences, University of California, Davis, CA, USA
    • Center for Healthcare Policy and Research, University of California, Davis, CA, USA
    • Corresponding Author InformationCorresponding author at: Department of Communication, One Shields Avenue, University of California, Davis, CA 95616, USA. Tel.: +1 530 752 1221; fax: +1 530 752 6705.
    • ,
  • Laramie D. Taylor

      Affiliations

    • Department of Communication, University of California, Davis, CA, USA
    • Center for Healthcare Policy and Research, University of California, Davis, CA, USA
    • ,
  • Richard L. Kravitz

      Affiliations

    • Center for Healthcare Policy and Research, University of California, Davis, CA, USA
    • Department of Internal Medicine, University of California, Davis, CA, USA

Received 22 September 2009 ,Accepted 11 January 2010.

References 

  1. The Nielsen Company. U.S. ad spending fell 2.6% in 2008, Nielsen reports. News Release, March 13, 2009. [available online at http://blog.nielsen.com/nielsenwire/wp-content/uploads/2009/03/nielsen2008adspend-release.pdf].
  2. Kelly P. DTC advertising's benefits far outweigh imperfections. Health Aff. 2004;w4:246–248
  3. Bell RA, Wilkes MS, Kravitz RL. Advertising-induced prescription drug requests: patients’ anticipated reactions to a physician who refuses. J Fam Pract. 1999;48:446–452
  4. Robinson AR, Hohmann KB, Rifkin JI, Gilroy CM, Pickard JA, Anderson RJ. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med. 2004;164:427–432
  5. National Conference of State Legislatures. Marketing and direct-to-consumer advertising (DTCA) of pharmaceuticals. Online report, available at http://www.ncsl.org/default.aspx?tabid=14461. [accessed September 21, 2009].
  6. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498–505
  7. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357:673–681
  8. Eysenbach G, Powell J, Englesakis M, Rizo C, Stern A. Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions. Brit Med J. 2004;328(7449):1166
  9. Fox S, Jones S. The social life of health information. Washington, DC: Pew Internet & American Life Project; 2009;
  10. Beaudoin CE, Chen-Chao T. Benefiting from social capital in online support groups: an empirical study of cancer patients. Cyberpsychol Behav. 2007;10:587–590
  11. Beltramini RF. Consumer believability of information in direct-to-consumer (DTC) advertising of prescription drugs. J Business Ethics. 2006;63:333–343
  12. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff. 2000;19(2):110–128
  13. Murray E, Lo B, Pollack L, Donelan K, Lee K. Direct-to-consumer advertising: public perceptions of its effects on health behavior, health care, and the doctor-patient relationship. J Am Board Fam Pract. 2004;17:6–18
  14. Singh T, Smith D. Direct-to-consumer prescription drug advertising: a study of consumer attitudes and behavioral intentions. J Consumer Market. 2005;22:369–378
  15. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14:651–657
  16. Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract. 2000;49:1092–1098
  17. Kravitz RL, Bell RA. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward. Clin Pharmacol Ther. 2007;82:360–362
  18. Macias W, Pashupati K, Lewis LS. A wonderful life of diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Health Commun. 2007;22:241–252
  19. Lacasse JR. Consumer advertising of psychiatric medications biases the public against nonpharmacological treatment. Ethical Hum Psychol Psychiatry. 2005;7:175–179
  20. Atkin JL, Beltramini RF. Exploring the perceived believability of DTC advertising in the US. J Market Commun. 2007;13:169–180
  21. Polen HH, Khanfar NM, Clauson KA. Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues. Health Market Q. 2009;26:42–55
  22. Morris LA, Brinberg D, Klimberg R, Rivera C, Millstein LG. The attitudes of consumers toward direct advertising of prescription drugs. Public Health Reports. 1986;101:82–89
  23. Perri M, Nelson AA. An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. J Health Care Market. 1987;7:35–41
  24. Williams JR, Hensell PJ. Direct-to-consumer advertising of prescription drugs. J Health Care Market. 1995;15:35–41
  25. Deshpande A, Menon A, Perri M, Zinkhan G. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective. J Health Commun. 2004;9:499–513
  26. Peyrot M, Alperstein NM, Van Doren D, Poli L. Direct to consumer ads can influence behavior. Market Health Serv. 1998;18(2):26–32
  27. Sumpradit N, Fors SW, McCormick L. Consumers’ attitudes and behavior toward prescription drug advertising. Am J Health Behav. 2002;26:68–75
  28. Herzenstein M, Misra S, Posavac S. How consumers’ attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Market Lett. 2005;15:201–212
  29. An S. Attitude toward direct-to-consumer advertising and drug inquiry intention: the moderating role of perceived knowledge. J Health Commun. 2007;12:567–580
  30. Martinez LS, Lewis N. The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth. J Health Commun. 2009;14:246–261
  31. Huang AJ. The rise of direct-to-consumer advertising of prescription drugs in the United States. J Amer Med Assoc. 2000;284:2240
  32. Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, et al. Influence of patients’ requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. J Amer Med Assoc. 2005;293:1995–2002
  33. Block AE. Cost and benefits of direct-to-consumer advertising: the case of depression. Pharmacoeconomics. 2007;25:511–521
  34. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;42:1176–1185
  35. France CM, Lysaker PH, Robinson RP. The “chemical imbalance” explanation for depression: origins, lay endorsements, and clinical implications. Prof Psychol: Res Pract. 2007;38:41–420
  36. Lacasse LR, Leo J. Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med. 2005;2(12):e392
  37. Chananie RA. Psychopharmaceutical advertising strategies: empowerment in a pill?. Sociol Spectr. 2005;25:487–518
  38. Gilbody S, Wilson P, Watt I. Direct-to-consumer advertising of psychotropics: an emerging and evolving form of pharmaceutical company influence. Br J Psychiatry. 2004;185:1–2
  39. Grow JM, Park JS, Han X. “Your life is waiting!”: Symbolic meanings in direct-to-consumer antidepressant advertising. J Commun Inquiry. 2006;30:163–188
  40. Park JS, Grow JM. The social realty of depression: DTC advertising of antidepressants and perceptions of the prevalence and lifetime risk of depression. J Business Ethics. 2008;79:379–393
  41. An S. Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: application of the availability heuristic. Health Commun. 2008;23:499–505
  42. Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–1292
  43. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334
  44. Feldman MD, Franks P, Epstein RM, Franz CE, Kravitz RL. Do patient requests for antidepressants enhance or hinder physicians’ evaluation of depression? A randomized controlled trial. Med Care. 2006;44:1107–1113
  45. Lorence D, Churchill R. A study of the web as DTC drug marketing agent. J Med Syst. 2007;31:551–556
  46. Lee AL. Changing effects of direct-to-consumer broadcast drug advertising information sources on prescription drug requests. Health Commun. 2009;24:361–376

PII: S0738-3991(10)00023-6

doi: 10.1016/j.pec.2010.01.014

Patient Education and Counseling
Volume 81, Issue 2 , Pages 245-250 , November 2010

Article Tools